Obesity is a common and challenging problem that often leads to other
medical problems, including type II diabetes, hyperlipidemia, hyperten
sion, coronary artery disease, and degenerative joint disease. Weight
loss, which is central to the dietary treatments for obesity, is often
of limited success. Recent studies have documented the safety and eff
icacy of certain appetite suppressants for assisting in long-term weig
ht loss and maintenance of weight loss. Since appetite suppressants, a
lone or in combination, have been documented to be safe and effective
adjuncts for treating obesity and complicated obesity, physicians shou
ld consider using these agents in the pharmacotherapy for obese patien
ts.